1,961
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Quality of life and patient-reported symptoms in a Phase 4, real-world study of tildrakizumab in patients with moderate-to-severe psoriasis: Week 28 interim analysis

ORCID Icon, , &
Article: 2200872 | Received 07 Feb 2023, Accepted 21 Mar 2023, Published online: 31 May 2023